New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension

Christopher J. Mullin, Stephen C. Mathai

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of review: Pulmonary hypertension is a common complication of systemic sclerosis (SSc), and remains a leading cause of morbidity and mortality. We will review recent developments in the recognition, classification and treatment of pulmonary hypertension in SSc. Recent findings: Advances in screening for pulmonary arterial hypertension (PAH) and use of exercise haemodynamics may help to identify pulmonary vascular disease earlier in SSc. Recent studies have led to changes in recommendations for adjunct therapy and selection of pulmonary vasodilators for the treatment of SSc-associated PAH. Summary: Recent advances in the diagnosis, classification and management of pulmonary hypertension in SSc have continued to improve our understanding of this challenging disease. Ongoing investigation in the pathogenesis of this disease will afford the opportunity to develop targeted therapies to improve outcomes for SSc patients with pulmonary hypertension.

Original languageEnglish (US)
Pages (from-to)561-567
Number of pages7
JournalCurrent opinion in rheumatology
Volume29
Issue number6
DOIs
StatePublished - Nov 1 2017

Keywords

  • exercise
  • pulmonary hypertension
  • screening
  • systemic sclerosis
  • therapy

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension'. Together they form a unique fingerprint.

Cite this